SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-001530
Filing Date
2021-01-29
Accepted
2021-01-29 09:15:28
Documents
17
Period of Report
2021-01-29
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20210128_8k.htm   iXBRL 8-K 30744
2 EXHIBIT 3.1 ex_223281.htm EX-3.1 6765
3 EXHIBIT 99.1 ex_223282.htm EX-99.1 9568
8 ex_223282img001.jpg GRAPHIC 4564
9 mbrx20210128_8kimg001.jpg GRAPHIC 3620
  Complete submission text file 0001437749-21-001530.txt   215673

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20210129.xsd EX-101.SCH 3701
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20210129_def.xml EX-101.DEF 12748
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20210129_lab.xml EX-101.LAB 17109
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20210129_pre.xml EX-101.PRE 13067
10 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20210128_8k_htm.xml XML 2837
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 21568419
SIC: 2834 Pharmaceutical Preparations